Andere Sprachen Indivior Pharmaceuticals, Inc. London S.E.

Aktien

A42086

US45579U1097

INDV

Pharmazeutika

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:04 24.07.2025			% 5 Tage	Veränd. 1. Jan.
1’238.00 ^GBX	+1.56%		+5.27%	+20.90%

26.02.	Indivior Pharmaceuticals, Inc., Q4 2025 Earnings Call, Feb 26, 2026
26.02.	Sektor-Update: Gesundheitswesen	MT

Andere Sprachen

26.02.	Sector Update: Health Care
26.02.	Indivior's Q4 Adjusted Earnings, Revenue Rise; Reaffirms 2026 Guidance
26.02.	Indivior Pharmaceuticals, Inc. Reaffirms Earnings Guidance for the Full-Year 2026
26.02.	Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Reports Q4 Revenue $358.0M, vs. FactSet Est of $305.6M
26.02.	Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Posts Q4 Adjusted EPS $0.82 per Share, vs. FactSet Est of $0.67
26.02.	Indivior Pharmaceuticals : FINAL Indivior Corporate Investor Deck
26.02.	Indivior Pharmaceuticals : FINAL Press Release
26.02.	Indivior Pharmaceuticals : FINAL Indivior Q4 Financial Results Deck
26.02.	Indivior Pharmaceuticals, Inc. announces an Equity Buyback for $400 million worth of its shares.
26.02.	Indivior Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
26.02.	Indivior PLC authorizes a Buyback Plan.
29.01.	Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26??
26.01.	Indivior Pharmaceuticals Completes Redomiciliation to US From UK
26.01.	Indivior Announces Completion of Redomiciliation to the United States
08.01.	Indivior PLC Provides Earnings Guidance for the Full Year 2026
08.01.	Indivior Expects Up to $1.20 Billion in 2026 Net Revenue
08.01.	(INDV) Indivior Expects 2026 Revenue Range $1.13B - $1.2B, vs. FactSet Est of $1.19B
08.01.	Indivior : Financial Document
08.01.	Indivior Provides Full-Year 2026 Financial Guidance and Business Update
22.12.	Indivior Joins S&P SmallCap 600 Index
22.12.	Indivior Announces Inclusion in the S&P SmallCap 600® Index
22.12.	Indivior PLC(NasdaqGS:INDV) added to S&P 1000
22.12.	Indivior PLC(NasdaqGS:INDV) added to S&P Pharmaceuticals Select Industry Index
22.12.	Indivior PLC(NasdaqGS:INDV) added to S&P 600 Health Care
22.12.	Indivior PLC(NasdaqGS:INDV) added to S&P Composite 1500